InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by CALLICUTT JACK W. Officer active across 1 company, notably Galectin Therapeutics INC. Aggregated, 2 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €5k. History available since 17 November 2022. The latest transaction was disclosed on 23 December 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations